Slán NYC

Slán NYC Menopause Management, Metabolic Management, Healthy Aging,
Libido Support for Men & Women, Gynecology & Longevity

09/18/2026

One menopause myth we need to retire: “If you carry a BRCA mutation, you can’t take hormone therapy.”

The evidence is more nuanced than that.

For BRCA1/BRCA2 mutation carriers without a personal history of breast cancer, research suggests menopause hormone therapy after risk-reducing o***y removal is not automatically associated with increased breast cancer risk. A recent cohort study found estrogen-only therapy was not associated with increased breast cancer risk — and was associated with lower risk among women with BRCA1 pathogenic variants. Combined estrogen-progestin therapy showed no significant association with increased breast cancer risk in the overall study population. (PubMed Central (PMC)⁠)

This does not mean HRT/MHT is right for everyone.

BRCA status, personal breast cancer history, age, uterus status, type of hormone therapy, route, dose, timing, surgical history, and oncology guidance all matter.

But if you are BRCA-positive and struggling with surgical menopause, hot flashes, sleep disruption, mood changes, vaginal symptoms, bone loss risk, or quality-of-life changes, the conversation should not end with “absolutely not.”

You deserve individualized counseling, not blanket dismissal.

09/16/2026

GLP-1 medications are becoming much more than a weight-loss conversation.

A large 2025 systematic review and meta-analysis in JACC pooled 21 randomized trials with nearly 100,000 patients and found high-certainty evidence that GLP-1 receptor agonists reduced major adverse cardiovascular events, cardiovascular death, and all-cause mortality compared with placebo or control treatment. (PubMed⁠)

That matters because the benefits appear to extend beyond blood sugar control alone.

The study also found reductions in myocardial infarction, heart failure, acute kidney failure, and serious adverse events — while also noting increased gastrointestinal and gallbladder risks. (PubMed⁠)

So the takeaway is not “everyone should be on a GLP-1.”

The takeaway is: these medications are reshaping how we think about metabolic health, cardiovascular prevention, inflammation, and long-term risk — and they should be prescribed and monitored thoughtfully by a qualified clinician.

At Slán NYC, we look at the full picture: weight, glucose, inflammation, cholesterol, blood pressure, menopause status, cardiovascular risk, and your long-term health goals.

09/14/2026

This matters because women are working longer, leading companies, managing teams, and carrying institutional knowledge — often while navigating hot flashes, sleep disruption, brain fog, migraines, heavy bleeding, anxiety, or other symptoms that can affect daily work.

And yet too many women still feel they have to suffer quietly or leave the workforce early.

A reasonable accommodation should not be controversial. Flexibility, temperature control, access to water, breathable uniforms, rest breaks, remote work when appropriate, and dignity in the conversation can make a real difference.

This is not about special treatment.

It is about recognizing menopause as a legitimate health transition — and making sure experienced women are supported, protected, and not pushed out.

Progress.

09/10/2026

Overheard at the Open. Also true in midlife. 💛 +

09/08/2026

Heat index: high. Hot flashes: also treatable. 😅🎾 + USOpen

09/04/2026

Things we need to stop accepting in menopause care:

Expensive products that prey on women looking for real help.

Being told labs are “normal” when symptoms are clearly not.

Dismissing women when they say, “I don’t feel like myself.”

Layering on antidepressants, anxiety medication, sleep medication, and osteoporosis medication — without ever asking whether menopause hormone therapy may be appropriate.

To be clear: every patient is different, and medications can absolutely have a place.

But women deserve to be heard, evaluated fully, and offered evidence-based options — not dismissed, upsold, or rushed out the door.

At Slán NYC, we believe menopause care should be thoughtful, individualized, and rooted in real medicine.

09/02/2026

HRT has a new name, and the shift matters.

For years, many people have called it hormone replacement therapy, or HRT. But in menopause care, the more precise term is now menopause hormone therapy, or MHT.

That language matters because menopause care is not about saying your body is “broken.” It is about treating symptoms, supporting quality of life, and, for the right patient, considering longer-term health factors with an individualized plan.

This terminology shift is happening alongside updated conversations about menopause treatment, including recent FDA labeling changes intended to clarify risk-benefit information for menopausal hormone therapy products. The FDA notes that MHT is also commonly referred to as HRT. (U.S. Food and Drug Administration)

To be clear: MHT is not one-size-fits-all, and it is not risk-free.

The right decision depends on your symptoms, age, menopause timing, uterus status, personal and family history, breast cancer risk, cardiovascular risk, clotting risk, and the specific type, dose, and route of therapy.

But the bigger point is this: the conversation is finally becoming more nuanced.

Women deserve accurate information, individualized care, and clinicians who know how to talk about menopause without fear, dismissal, or outdated assumptions.

08/31/2026

We are not talking enough about cancer survivorship and sexual health.

Sexual dysfunction is common after cancer treatment, especially for women who have experienced surgery, chemotherapy, radiation, hormone therapy, or sudden surgical menopause.

Symptoms may include vaginal dryness, pain with in*******se, vaginal atrophy, decreased desire, pelvic floor pain, or vaginal narrowing and stenosis. These symptoms are real — and they deserve care.

Most importantly: there are options.

Depending on the patient and cancer history, treatment may include non-hormonal vaginal moisturizers and lubricants, pelvic floor physical therapy, vaginal dilators, pain management strategies, and, in select cases, carefully considered local vaginal hormone therapy in collaboration with the oncology team.

Guidelines support clinicians having these conversations with patients, and a review found sexual health concerns can affect up to 78% of gynecologic cancer survivors. (ASCO Publications)

Cancer survivors deserve more than survival. They deserve education, options, comfort, intimacy, and quality of life.

At Slán NYC, we can help you start that conversation.

08/28/2026

GLP-1 medications are changing the conversation in metabolic health — and now, early research is looking at their potential role in inflammatory skin disease.

Emerging evidence suggests GLP-1 receptor agonists may help improve certain dermatologic conditions through a combination of metabolic effects, weight reduction, and possible direct immune-modulating effects. Reviews have highlighted early signals in conditions like psoriasis and hidradenitis suppurativa, or HS. (PubMed)

In psoriasis, some studies have reported improvements in severity scores, especially among patients with metabolic disease or diabetes. In HS, early data suggest GLP-1 medications such as liraglutide and semaglutide may help reduce systemic inflammation and disease activity in selected patients. (PubMed)

This is promising — but it is still early.

GLP-1s are not currently a replacement for standard dermatology care, and they are not right for everyone. But for patients who have both metabolic risk and inflammatory skin disease, this is an important area to watch.

More research is coming. More answers are coming. And for patients who have struggled with these chronic, inflammatory conditions, that hope matters.

As always, these medications should be prescribed and monitored by a qualified clinician.

08/25/2026

The US Open is on this week 🎾 — but here’s the match that matters more: you and your doctor.
Not opponents. Doubles partners. So many women tell me they spent years trying to understand their own bodies alone — and that’s the part I want to change. You bring what you’re feeling, I bring what I know. That’s the team.
Save this for when you’re ready to play with a partner. 💛

Address

54 W 21st Street
New York, NY
10010

Website

Alerts

Be the first to know and let us send you an email when Slán NYC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Category